Professor Will Irving

Professor Will Irving

Professor of Virology

+44 115 823 0752 View full bio
Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

Clinical virology, especially in relation to viral hepatitis and the human herpes viruses. This encompasses diagnosis, management and pathogenesis of disease.

Publications
Title
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: a
Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatm
Virology Question and Answer Scheme (VIROQAS) Hepatitis C virus infection
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
In silico and in vitro interrogation of a widely used HEV RT-qPCR assay for detection of the species
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected p
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and
Using Surveillance Data to Determine Treatment Rates and Outcomes for Patients With Chronic Hepatiti
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis
Equilibrative nucleoside transporter 1 (ent1) expression is highly variable in primary human hepatoc
Hepatitis E: An emerging infection in high income countries
Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan:
Predictors of hepatitis C treatment response: what’s new?
HCV Research UK: A UK national resource to support research into HCV infection
Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease pheno
Next Generation Sequencing and in Vitro Characterization Reveal Population Bottlenecks and Fixation
Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombo
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B acro
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected p
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cir
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistan
Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis
Autoantibodies in chronic hepatitis C virus infection and their association with disease profile